Randomized Control Trial of a Virtual Patient Advocate for Preconception Care

NACompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

January 31, 2019

Conditions
Preconception Care
Interventions
BEHAVIORAL

Virtual Patient Advocate (VPA)

Intervention participants will have access to the Virtual Patient Advocate (VPA) system for a period of 12 months. They will be encouraged to log on every two weeks or twice a month, but frequency and duration of conversations with the VPA is at the discretion of the participant.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Northeastern University

OTHER

collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Boston Medical Center

OTHER

NCT01827215 - Randomized Control Trial of a Virtual Patient Advocate for Preconception Care | Biotech Hunter | Biotech Hunter